Nurix Therapeutics, Inc. SEC filings NRIX
Nurix Therapeutics, Inc. has 561 filings in SEC EDGAR's recent list, going back to May 15, 2012. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Nov 30, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 13, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on November 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| S-8 | Employee stock plan registration | Jan 28, 2026 | — |
| 424B5 | Prospectus supplement | Oct 22, 2025 | — |
| FWP | Free writing prospectus | Oct 22, 2025 | — |
| S-8 | Employee stock plan registration | Jan 28, 2025 | — |
| 424B5 | Prospectus supplement | Oct 31, 2024 | — |
| S-8 | Employee stock plan registration | Oct 31, 2024 | — |
| 424B5 | Prospectus supplement | Jul 11, 2024 | — |
| S-3ASR | Automatic shelf registration | Jun 11, 2024 | — |
| 424B5 | Prospectus supplement | Apr 12, 2024 | — |
| 424B5 | Prospectus supplement | Apr 11, 2024 | — |
| S-8 | Employee stock plan registration | Feb 15, 2024 | — |
| S-8 | Employee stock plan registration | Feb 9, 2023 | — |
| POS AM | Filing | Feb 9, 2023 | — |
| 424B5 | Prospectus supplement | Jul 8, 2022 | — |
| 424B5 | Prospectus supplement | Jul 8, 2022 | — |
| S-8 | Employee stock plan registration | Jan 28, 2022 | — |
| S-3ASR | Automatic shelf registration | Aug 4, 2021 | — |
| 424B4 | Prospectus | Mar 5, 2021 | — |
| S-1 | Registration statement | Mar 2, 2021 | — |
| S-8 | Employee stock plan registration | Feb 16, 2021 | — |
| 424B4 | Prospectus | Jul 24, 2020 | — |
| S-8 | Employee stock plan registration | Jul 24, 2020 | — |
| S-1/A | Amended registration statement | Jul 23, 2020 | — |
| S-1/A | Amended registration statement | Jul 20, 2020 | — |
| S-1 | Registration statement | Jul 2, 2020 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NRIX (Nasdaq)
- Fiscal year ends
- November 30
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1549595
- Former names
- Nurix, Inc. (until Sep 18, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.